SCHEMBL5732864

SCHEMBL5732864

CC/C1=C(\c2ccccc2)c2ccc(OCCN(C)C)cc2CCc2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.62
ESR2 Q92731 6/20 0.47
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
KMT2A Q03164 1/20 0.43
MCHR1 Q99705 1/20 0.43
HTR7 P34969 1/20 0.43
EBP Q15125 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
LTA4H P09960 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PDK2 Q15119 1/20 0.42
LSS P48449 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5732868 1.00 ESR1 (0.62) ESR1ESR2ADORA2AADORA1KMT2A
SCHEMBL6756238 0.82 ESR1 (0.80) ESR1ESR2EBPSIGMAR1LSS
SCHEMBL17152127 0.79 ESR1 (0.69) ESR1ESR2HTR7EBPSIGMAR1
SCHEMBL6756246 0.76 ESR1 (0.72) ESR1ESR2EBPSIGMAR1LSS
SCHEMBL13350201 0.76 ESR1 (0.71) ESR1ESR2EBPSIGMAR1
SCHEMBL6756233 0.73 ESR1 (0.68) ESR1ESR2ADORA2AADORA1KMT2A
SCHEMBL8004280 0.73 ESR1 (0.70) ESR1ESR2EBPSIGMAR1LTA4H
SCHEMBL11880808 0.70 ESR1 (0.72) ESR1ESR2KMT2AEBPSIGMAR1
SCHEMBL1793325 0.69 HRH3 (0.54) ESR1KMT2ALTA4HKDM4EALDH1A1
SCHEMBL16938064 0.69 HTR2B (0.69) ESR1KMT2AHTR7SIGMAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127045-B1 TRIPHENYLBUTENE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS ASTRAZENECA AB (SE) 2006-11-02 EP disclosed
US-6489481-B1 COMPOUNDS USED FOR TREATMENT AND/OR PREVENTION OF NEURONAL APOPTOSIS AND/OR EXCITOTOXICITY RELATED NEUROLOGICAL DISORDERS ASTRAZENECA AB (SE) 2002-12-03 US disclosed